Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes

NCT06478186 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Osteoarthritis, Knee
Diabetes Mellitus, Type 2

Interventions

DRUG: triamcinolone acetonide extended-release injectable suspension; TCA-ER
DRUG: Triamcinolone Acetonide- Immediate Release;TCA-IR

Sponsor

University of Kansas Medical Center